John Harold Leaman Impel Pharmaceuticals Inc (IMPL) insider trading activity

IMPL Quotes by TradingView

John Harold Leaman is Chief Fin. & Business Officer of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 6,944 shares of IMPL, which is worth approximately $138. The most recent transaction as insider was on Dec 31, 2022, when has been sold 3,627 shares (Common Stock) at a price of $3.75 per share, resulting in proceeds of $13,601. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.94K
0% 3M change
0% 12M change
Total Value Held $138

John Harold Leaman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2022
SELL
Payment of exercise price or tax liability
$13,601 $3.75 p/Share
3,627 Reduced 34.31%
6,944 Common Stock
Dec 31 2022
BUY
Exercise of conversion of derivative security
-
10,571 Added 50.0%
10,571 Common Stock
JHL

John Harold Leaman

Chief Fin. & Business Officer
Seattle, WA

Track Institutional and Insider Activities on IMPL

Follow IMPEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMPL shares.

Notify only if

Insider Trading

Get notified when an Impel Pharmaceuticals Inc insider buys or sells IMPL shares.

Notify only if

News

Receive news related to IMPEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMPL